AKT1 and hepatocellular carcinoma: According to our findings, usenamine A treatment suppressed the proliferation and invasion of human HCC cells, and inhibited ID1 expression by suppressing AKT/mTOR/STAT3 signaling and promoting ubiquitin–proteasome-mediated degradation in HCC cells.